首页 | 本学科首页   官方微博 | 高级检索  
检索        

吡咯烷二硫代氨基甲酸酯对2型糖尿病大鼠肝糖原合成的影响
引用本文:张利众,赵瑞景,刘建坤,高书涛,朱铁年.吡咯烷二硫代氨基甲酸酯对2型糖尿病大鼠肝糖原合成的影响[J].中国病理生理杂志,2010,26(12):2442-2446.
作者姓名:张利众  赵瑞景  刘建坤  高书涛  朱铁年
作者单位:1. 河北医科大学第四医院内分泌科 河北 石家庄 050011;
2. 解放军白求恩国际和平医院肿瘤科, 河北 石家庄 050082;
3. 河北医科大学免疫教研室, 河北 石家庄050011
基金项目:河北省自然科学基金,河北省教育厅资助项目,河北省卫生厅资助项目
摘    要:目的:探讨吡咯烷二硫代氨基甲酸酯(PDTC)对糖尿病大鼠肝糖原合成的影响及其机制。方法:雄性Wistar大鼠,随机分为2组:正常饮食组和高脂饮食组。喂养8周后,高脂饮食组大鼠腹腔注射单剂量链脲佐菌素(STZ)27 mg/kg复制2型糖尿病大鼠模型,2型糖尿病大鼠造模成功后随机分为3组:糖尿病模型组、PDTC治疗组和胰岛素治疗组。PDTC治疗组大鼠每天腹腔注射PDTC(50 mg/kg)1次;其它各组每天同一时间注射相同体积的生理盐水,胰岛素治疗组大鼠在处死前1 h腹腔注射胰岛素(1 U/kg)1次。治疗1周后尾静脉采血测定各组大鼠血糖水平,然后断头处死大鼠,测定肝组织中肝糖原的含量,采用Western blotting分析大鼠肝脏中蛋白激酶B(PKB/Akt)和糖原合成酶激酶-3β(GSK-3β)磷酸化水平的变化。结果:糖尿病模型组与正常饮食组大鼠相比血糖显著升高(P0.01);肝糖原含量明显减少(P0.01);肝脏中Akt及GSK-3β磷酸化水平明显降低(P0.01)。与糖尿病模型组大鼠相比,PDTC治疗组与胰岛素治疗组大鼠肝糖原合成均显著增加(P0.01);血糖均明显降低(P0.01);肝脏中Akt和GSK-3β磷酸化水平均明显增加(P0.01)。结论:PDTC可通过调控Akt/GSK-3β活性,增加肝糖原合成,降低血糖。

关 键 词:吡咯烷二硫代氨基甲酸酯  糖尿病  肝糖原  糖原合成酶激酶-3β  蛋白激酶B  
收稿时间:2010-05-12

Effects of pyrrolidine dithiocarbamate on synthesis of hepatic glycogen in diabetic rats
ZHANG Li-zhong,ZHAO Rui-jing,LIU Jian-kun,GAO Shu-tao,ZHU Tie-nian.Effects of pyrrolidine dithiocarbamate on synthesis of hepatic glycogen in diabetic rats[J].Chinese Journal of Pathophysiology,2010,26(12):2442-2446.
Authors:ZHANG Li-zhong  ZHAO Rui-jing  LIU Jian-kun  GAO Shu-tao  ZHU Tie-nian
Institution:1. Department of Endocrinology, The Forth Hospital of Hebei Medical University, Shijiazhuang 050011, China;
2. Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang 050082, China;
3. Department of Immunology, Hebei Medical University, Shijiazhuang 050011, China
Abstract:AIM: To determine the effect of pyrrolidine dithiocarbamate on hepatic glycogen synthesis and its mechanism in diabetic rats. METHODS: Male Wistar rats were randomly divided into normal diet group and high-fat diet group. After 8 weeks of feeding, the rats in high-fat diet group were injected intraperitoneally with a single dose of streptozotocin (27 mg/kg) to induce type 2 diabetes. The diabetes rats were randomly divided into 3 groups: diabetes mellitus group (DM), PDTC-treated group (DM+PDTC) and insulin-treated group (DM+INS). The rats in PDTC-treated group were injected with PDTC (50 mg/kg) intraperitoneally daily. At the same time, the rats in normal diet group, DM group and insulin-treated group were injected with equivalent volume of saline in the same way. The rats in insulin-treated group were injected with insulin (1 U/kg) 1 h before killed. After the treatment was taken for 1 week, the levels of blood glucose were measured, then the animals in all groups were killed. The liver glycogen content was detected, and the levels of GSK-3β and Akt phosphorylation in the liver tissues were analyzed by Western blotting. RESULTS: The blood glucose level and liver glycogen content were significantly higher, and the levels of GSK-3β and Akt phosphorylation were lower in DM group than those in normal-diet group (P<0.01). Compared with DM group, the glycogen content, the phosphorylation of Akt and GSK-3β in the liver tissues in DM+PDTC group and DM+INS group increased significantly (P<0.01), and the blood glucose levels decreased (P<0.01). CONCLUSION: PDTC increases the synthesis of liver glycogen and decreases the level of blood glucose by regulating the activity of Akt and GSK-3β in the liver.
Keywords:Pyrrolidine dithiocarbamate  Diabetes mellitus  Hepatic glycogen  Glycogen synthase kinase-3β  Protein kinase B
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号